Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment



Rating:

Share or cite this content

Citations should be made in the following way:
I. LENEVA (Moscow, Russian Federation), E. Faizuloev (Moscow, Russian Federation), N. Kartashova (Moscow, Russian Federation), A. Gracheva (Moscow, Russian Federation), E. Korchevaya (Moscow, Russian Federation), A. Poromov (Moscow, Russian Federation), G. Ignatyev (Moscow Region, Russian Federation), V. Volok (Moscow Region, Russian Federation), L. Kozlovskaya (Moscow Region, Russian Federation), S. Loginova (Moscow, Russian Federation), V. Shchukina (Moscow, Russian Federation), R. Khamitov (Vladimir Region,Volginsky, Russian Federation). Inhibition by umifenovir is broadly effective against coronaviruses. 2660

Member's Comments

No comment yet.

Related content which might interest you: Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model Source: Eur Respir J 2011; 38: 401-408 Year: 2011 Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation Source: Eur Respir J 2011; 37: 44-52 Year: 2011 Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 LATE-BREAKING ABSTRACT: Effects of a single treatment with PC786, a novel inhibitor of respiratory syncytial virus replication, on viral load and biomarkers in fully differentiated human bronchial epithelial cells Source: International Congress 2016 – Translational research in respiratory infections Year: 2016 Influenza infection of monocyte-macrophages is insensitive to inhibition by NH4Cl Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009 Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus. Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Labyrinthopeptin A1 and A2 efficiently inhibit cell entry of hRSV isolates Source: International Congress 2017 – From microbiology to clinical work Year: 2017 Targeting viruses and bacteria Source: Annual Congress 2007 - Novel therapies for severe asthma Year: 2007 Inducible epithelial resistance modulates innate antiviral signaling against coronavirus and influenza Source: Virtual Congress 2021 – Back to infection basics Year: 2021 COVID-19 vaccination and more Source: ERS webinar 2021: COVID-19 vaccination and more Year: 2021 New treatments for RSV and other viruses, including update on vaccines Source: ERS Courses: Paediatric respiratory infections Year: 2019 The efficacy of the decamethoxin against simple and complex viruses Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020 LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus Source: Annual Congress 2013 –Viral infections: what is new? Year: 2013 Lymphocytes mediate the anti-apoptotic effect of respiratory syncytial virus on human neutrophils Source: Annual Congress 2007 - Bronchiolitis - genetics and immunity Year: 2007 Adeno-associated virus serotype 5 efficiently transduces human respiratory epithelium Source: Eur Respir J 2001; 18: Suppl. 33, 407s Year: 2001 IP-10 is selectively produced in the airways upon respiratory virus infection Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Protein tyrosine phosphatase 1B negatively regulates S100A9 mediated apoptosis during respiratory syncytial virus infection Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015 Inhibition of rhinovirus infections Source: Annual Congress 2010 - Novel molecular targets for inflammatory and infectious lung diseases Year: 2010 Use of recombinant sendai virus for efficient gene transfer to differentiated human airway epithelium Source: Eur Respir J 2002; 20: Suppl. 38, 170s Year: 2002 LATE-BREAKING ABSTRACT: The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV) Source: International Congress 2014 – Respiratory infections in children Year: 2014